These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2836931)

  • 21. Serotonin binding in human platelets.
    Schick PK; McKean ML
    Biochem Pharmacol; 1979 Sep; 28(17):2667-70. PubMed ID: 518679
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 23. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Binding of 5-hydroxytryptamine to hydrophobic brain proteins. Characterization and subcellular localization of brain proteins].
    Cabello FM
    Acta Cient Venez; 1981; 32(3):232-5. PubMed ID: 7188514
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
    Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
    Seong CM; Park WK; Park CM; Kong JY; Park NS
    Bioorg Med Chem Lett; 2008 Jan; 18(2):738-43. PubMed ID: 18053713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in brain serotonin metabolism and [3H]-serotonin receptor binding during recall of conditioned passive avoidance in rats].
    Molodtsova GF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(4):533-41. PubMed ID: 15481391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-species variants of the 5-HT3 receptor.
    Kilpatrick GJ; Tyers MB
    Biochem Soc Trans; 1992 Feb; 20(1):118-21. PubMed ID: 1633936
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral indices of central serotonin function in humans.
    Murphy DL
    Ann N Y Acad Sci; 1990; 600():282-95; discussion 295-6. PubMed ID: 2252316
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioligand binding to solubilized 5-HT3 receptors.
    Fletcher S; Barnes NM
    Methods Mol Biol; 1999; 106():49-71. PubMed ID: 9921499
    [No Abstract]   [Full Text] [Related]  

  • 34. Suicide and serotonin receptors.
    Stanley M; Mann JJ
    Lancet; 1984 Feb; 1(8372):349. PubMed ID: 6141420
    [No Abstract]   [Full Text] [Related]  

  • 35. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
    Leysen JE; Van Gompel P; Gommeren W
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic studies of 5HT2 receptors.
    Saavedra JM; Himeno A
    Adv Exp Med Biol; 1991; 294():107-13. PubMed ID: 1772060
    [No Abstract]   [Full Text] [Related]  

  • 37. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor.
    Kikuchi C; Nagaso H; Hiranuma T; Koyama M
    J Med Chem; 1999 Feb; 42(4):533-5. PubMed ID: 10052959
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-HT6 receptor ligands and their antipsychotic potential.
    Arnt J; Olsen CK
    Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
    [No Abstract]   [Full Text] [Related]  

  • 39. [Characterization of serotonergic receptors].
    Leysen JE
    Rev Med Liege; 1988 Mar; 43 Suppl 1():12-21. PubMed ID: 2836931
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.